Here's the live share price of Syngene International along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Syngene International | -1.90 | 14.99 | 0.76 | -27.14 | -24.86 | -13.04 | -4.78 |
| Sun Pharmaceutical Industries | 2.16 | 7.80 | 8.37 | 8.82 | 4.59 | 24.30 | 21.48 |
| Divi's Laboratories | 3.13 | 14.07 | 9.69 | 0.25 | 12.60 | 26.85 | 10.15 |
| Torrent Pharmaceuticals | 4.41 | 8.66 | 9.53 | 14.64 | 37.49 | 37.95 | 25.91 |
| Cipla | 2.89 | 10.85 | 0.39 | -10.97 | -9.35 | 13.05 | 8.40 |
| Lupin | 3.22 | 3.68 | 8.14 | 19.65 | 18.08 | 48.09 | 14.23 |
| Dr. Reddy's Laboratories | -2.26 | 8.52 | 1.42 | 7.89 | 12.56 | 9.63 | 3.94 |
| Mankind Pharma | 8.04 | 18.85 | 16.54 | 8.54 | -0.29 | 19.45 | 11.25 |
| Zydus Lifesciences | 5.20 | 5.21 | 1.61 | -0.96 | 7.59 | 21.33 | 8.49 |
| Aurobindo Pharma | 7.12 | 11.49 | 23.91 | 29.09 | 28.51 | 33.98 | 7.28 |
| Glenmark Pharmaceuticals | -1.66 | 8.80 | 19.77 | 29.08 | 67.09 | 60.82 | 30.47 |
| Alkem Laboratories | 3.02 | 6.10 | -3.13 | -1.98 | 12.72 | 16.50 | 12.94 |
| Laurus Labs | 11.86 | 13.54 | 24.68 | 22.77 | 109.80 | 54.98 | 20.17 |
| Biocon | 5.84 | 8.73 | 1.78 | -0.44 | 13.73 | 15.93 | -0.20 |
| Abbott India | 5.70 | 3.97 | -2.18 | -8.87 | -10.47 | 6.12 | 10.79 |
| Anthem Biosciences | 3.24 | 13.71 | 16.53 | 11.25 | 7.40 | 2.41 | 1.44 |
| GlaxoSmithKline Pharmaceuticals | 6.38 | 5.52 | -1.05 | -2.19 | -9.35 | 25.36 | 11.33 |
| Ipca Laboratories | 1.64 | 7.66 | 7.21 | 15.65 | 15.26 | 30.32 | 8.34 |
| Ajanta Pharma | 7.42 | 11.97 | 6.14 | 20.05 | 20.51 | 33.42 | 17.77 |
| J B Chemicals & Pharmaceuticals | 5.26 | 10.81 | 14.42 | 18.88 | 40.27 | 27.39 | 24.79 |
Over the last one year, Syngene International has declined 24.86% compared to peers like Sun Pharmaceutical Industries (4.59%), Divi's Laboratories (12.60%), Torrent Pharmaceuticals (37.49%). From a 5 year perspective, Syngene International has underperformed peers relative to Sun Pharmaceutical Industries (21.48%) and Divi's Laboratories (10.15%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 455.87 | 453.05 |
| 10 | 444.26 | 446.42 |
| 20 | 429.88 | 436.12 |
| 50 | 420.11 | 441.93 |
| 100 | 498.6 | 484.02 |
| 200 | 575.75 | 548.73 |
In the latest quarter, Syngene International remained same as its previous close in promoter holding, while DII stake increased to 26.44%, FII holding fell to 13.91%, and public shareholding moved up to 6.69% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 79,52,323 | 0.5 | 310.06 | |
| 57,46,009 | 2.98 | 224.04 | |
| 56,77,160 | 3.52 | 221.35 | |
| 55,71,925 | 0.47 | 217.25 | |
| 40,00,000 | 0.96 | 166 | |
| 42,07,261 | 2.71 | 164.04 | |
| 40,06,393 | 0.41 | 156.21 | |
| 39,03,263 | 1.01 | 152.19 | |
| 37,73,806 | 1 | 147.14 | |
| 37,70,138 | 1.15 | 147 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 05, 2026, 03:17 AM IST IST | Syngene Intl. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Apr 30, 2026, 11:01 PM IST IST | Syngene Intl. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Apr 30, 2026, 06:51 PM IST IST | Syngene Intl. - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Apr 30, 2026, 04:05 AM IST IST | Syngene Intl. - Syngene International Limited Has Informed The Exchange That Record Date For The Purpose Of Dividend Is June |
| Apr 30, 2026, 12:36 AM IST IST | Syngene Intl. - Intimation Of Change In Key Managerial Personnel (KMP) To Determine Materiality Of An Event Or Information |
Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937. Currently Company is involved in the business activities of Scientific research and development. Company's Total Operating Revenue is Rs. 3423.80 Cr. and Equity Capital is Rs. 402.90 Cr. for the Year ended 31/03/2026.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Syngene International is ₹459.00 as on May 08, 2026.
The Syngene International is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Syngene International is ₹18,528.41 Cr as on May 08, 2026.
Today’s highest and lowest price of Syngene International are ₹469.90 and ₹456.70.
The 52-week high/low is the highest and lowest price at which Syngene International stock has traded in the past 52-week or nearly a year. The 52-week high of Syngene International is ₹728.40 and 52-week low of Syngene International is ₹380.00 as on May 08, 2026.
The Syngene International has shown returns of -2.22% over the past day, 14.99% for the past month, 0.76% over 3 months, -24.86% over 1 year, -13.04% across 3 years, and -4.78% over 5 years.
P/E ratio of and PB ratio of Syngene International are 58.51 and 3.90 on May 08, 2026. While the company gives a dividend yield of 0.00 per annum.